171 related articles for article (PubMed ID: 30638176)
1. High expression of RAD51 promotes DNA damage repair and survival in KRAS-mutant lung cancer cells.
Hu J; Zhang Z; Zhao L; Li L; Zuo W; Han L
BMB Rep; 2019 Feb; 52(2):151-156. PubMed ID: 30638176
[TBL] [Abstract][Full Text] [Related]
2. Enhanced dependency of KRAS-mutant colorectal cancer cells on RAD51-dependent homologous recombination repair identified from genetic interactions in Saccharomyces cerevisiae.
Kalimutho M; Bain AL; Mukherjee B; Nag P; Nanayakkara DM; Harten SK; Harris JL; Subramanian GN; Sinha D; Shirasawa S; Srihari S; Burma S; Khanna KK
Mol Oncol; 2017 May; 11(5):470-490. PubMed ID: 28173629
[TBL] [Abstract][Full Text] [Related]
3. β1-Integrin Impacts Rad51 Stability and DNA Double-Strand Break Repair by Homologous Recombination.
Ahmed KM; Pandita RK; Singh DK; Hunt CR; Pandita TK
Mol Cell Biol; 2018 May; 38(9):. PubMed ID: 29463647
[TBL] [Abstract][Full Text] [Related]
4. Effects of Rad51 on survival of A549 cells.
Yu SS; Tu Y; Xu LL; Tao XQ; Xu S; Wang SS; Xiong YF; Mei JH
Asian Pac J Cancer Prev; 2015; 16(1):175-9. PubMed ID: 25640347
[TBL] [Abstract][Full Text] [Related]
5. The homologous recombination protein RAD51 is a promising therapeutic target for cervical carcinoma.
Chen Q; Cai D; Li M; Wu X
Oncol Rep; 2017 Aug; 38(2):767-774. PubMed ID: 28627709
[TBL] [Abstract][Full Text] [Related]
6. BRG1 promotes the repair of DNA double-strand breaks by facilitating the replacement of RPA with RAD51.
Qi W; Wang R; Chen H; Wang X; Xiao T; Boldogh I; Ba X; Han L; Zeng X
J Cell Sci; 2015 Jan; 128(2):317-30. PubMed ID: 25395584
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of DNA repair protein Rad51 in human tumour cell lines exposed to doxorubicin.
Koehn H; Magan N; Isaacs RJ; Stowell KM
Anticancer Drugs; 2007 Apr; 18(4):419-25. PubMed ID: 17351394
[TBL] [Abstract][Full Text] [Related]
8. Regulation of homologous recombinational repair by lamin B1 in radiation-induced DNA damage.
Liu NA; Sun J; Kono K; Horikoshi Y; Ikura T; Tong X; Haraguchi T; Tashiro S
FASEB J; 2015 Jun; 29(6):2514-25. PubMed ID: 25733566
[TBL] [Abstract][Full Text] [Related]
9. Targeting UHRF1-dependent DNA repair selectively sensitizes KRAS mutant lung cancer to chemotherapy.
Tian D; Tang J; Geng X; Li Q; Wang F; Zhao H; Narla G; Yao X; Zhang Y
Cancer Lett; 2020 Nov; 493():80-90. PubMed ID: 32814087
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell kill by c-MYC depletion: role of MYC-regulated genes that control DNA double-strand break repair.
Luoto KR; Meng AX; Wasylishen AR; Zhao H; Coackley CL; Penn LZ; Bristow RG
Cancer Res; 2010 Nov; 70(21):8748-59. PubMed ID: 20940401
[TBL] [Abstract][Full Text] [Related]
11. RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors.
Martin RW; Orelli BJ; Yamazoe M; Minn AJ; Takeda S; Bishop DK
Cancer Res; 2007 Oct; 67(20):9658-65. PubMed ID: 17942895
[TBL] [Abstract][Full Text] [Related]
12. Suppression of ERCC1 and Rad51 expression through ERK1/2 inactivation is essential in emodin-mediated cytotoxicity in human non-small cell lung cancer cells.
Ko JC; Su YJ; Lin ST; Jhan JY; Ciou SC; Cheng CM; Lin YW
Biochem Pharmacol; 2010 Feb; 79(4):655-64. PubMed ID: 19799875
[TBL] [Abstract][Full Text] [Related]
13. Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells.
Ko JC; Tsai MS; Weng SH; Kuo YH; Chiu YF; Lin YW
Toxicol Appl Pharmacol; 2011 Sep; 255(3):327-38. PubMed ID: 21810436
[TBL] [Abstract][Full Text] [Related]
14. U2AF1 mutation connects DNA damage to the alternative splicing of RAD51 in lung adenocarcinomas.
Chen C; Zhou P; Zhang Z; Liu Y
Clin Exp Pharmacol Physiol; 2022 Jul; 49(7):740-747. PubMed ID: 35434831
[TBL] [Abstract][Full Text] [Related]
15. The Tumor-Associated Variant RAD51 G151D Induces a Hyper-Recombination Phenotype.
Marsden CG; Jensen RB; Zagelbaum J; Rothenberg E; Morrical SW; Wallace SS; Sweasy JB
PLoS Genet; 2016 Aug; 12(8):e1006208. PubMed ID: 27513445
[TBL] [Abstract][Full Text] [Related]
16. Altered DNA repair and recombination responses in mouse cells expressing wildtype or mutant forms of RAD51.
Rukść A; Birmingham EC; Baker MD
DNA Repair (Amst); 2007 Dec; 6(12):1876-89. PubMed ID: 17719855
[TBL] [Abstract][Full Text] [Related]
17. Functional validation of miRNAs targeting genes of DNA double-strand break repair to radiosensitize non-small lung cancer cells.
Piotto C; Biscontin A; Millino C; Mognato M
Biochim Biophys Acta Gene Regul Mech; 2018 Dec; 1861(12):1102-1118. PubMed ID: 30389599
[TBL] [Abstract][Full Text] [Related]
18. The role of celecoxib in Rad51 expression and cell survival affected by gefitinib in human non-small cell lung cancer cells.
Ko JC; Wang LH; Jhan JY; Ciou SC; Hong JH; Lin ST; Lin YW
Lung Cancer; 2009 Sep; 65(3):290-8. PubMed ID: 19157634
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells.
Vernole P; Muzi A; Volpi A; Dorio AS; Terrinoni A; Shah GM; Graziani G
Mutat Res; 2009 May; 664(1-2):39-47. PubMed ID: 19428379
[TBL] [Abstract][Full Text] [Related]
20. Curcumin sensitizes lymphoma cells to DNA damage agents through regulating Rad51-dependent homologous recombination.
Zhao Q; Guan J; Qin Y; Ren P; Zhang Z; Lv J; Sun S; Zhang C; Mao W
Biomed Pharmacother; 2018 Jan; 97():115-119. PubMed ID: 29080451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
